The emerging approach of the medication represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide affects dual pathways – GLP-1 and GIP – resulting in https://tirzepatide-peptide251684.atualblog.com/48720832/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment